764P Survey on the practical implementation of BRCA gene and HRD-testing and PARP-inhibitor management in Germany: A national NOGGO/JAGO-AGO intergroup study

J. Baum, B.D. Nguyen, P. Meyer-Wilmes, A. Kreklau,C. Buschmann,S Boz,Christina Fotopoulou,Radoslav Chekerov,Elena-Ioana Braicu,Michael Hummel,Jalid Sehouli,Klaus Pietzner

ANNALS OF ONCOLOGY（2021）

引用 1|浏览2

暂无评分

摘要

Since the introduction of Poly (ADP-ribose) polymerase inhibitors (PARPi) the Breast Cancer gene (BRCA)-testing has evolved as a standard management in high grade ovarian cancer (EOC). The purpose of the study is to analyze the current implementation of BRCA testing and PARPi therapy for EOC in Germany.

查看译文

关键词

brca gene,hrd-testing,parp-inhibitor,jago-ago

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要